View in EDS HTML Full Text PDF Full Text

VEGF Signal Complexity Confers Resistance to Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in EGFR-Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: VEGF Signal Complexity Confers Resistance to Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in EGFR-Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer.
Authors: Hong S; Research Institute National Cancer Center Gyeonggi Republic of Korea., Yu N; Research Institute National Cancer Center Gyeonggi Republic of Korea., Cho JY; Research Institute National Cancer Center Gyeonggi Republic of Korea., Lee GK; Center for Lung Cancer National Cancer Center Hospital Gyeonggi-do Republic of Korea., Ahn BC; Research Institute National Cancer Center Gyeonggi Republic of Korea.; Center for Lung Cancer National Cancer Center Hospital Gyeonggi-do Republic of Korea., Lee Y; Research Institute National Cancer Center Gyeonggi Republic of Korea.; Center for Lung Cancer National Cancer Center Hospital Gyeonggi-do Republic of Korea., Sim H; National Cancer Center Graduate School of Cancer Science and Policy Gyeonggi Republic of Korea., Song BR; Research Institute National Cancer Center Gyeonggi Republic of Korea., Hwang M; Research Institute National Cancer Center Gyeonggi Republic of Korea., Kim S; Research Institute National Cancer Center Gyeonggi Republic of Korea., Kim JH; Research Institute National Cancer Center Gyeonggi Republic of Korea., Park C; Research Institute National Cancer Center Gyeonggi Republic of Korea., Han JY; Research Institute National Cancer Center Gyeonggi Republic of Korea.; Center for Lung Cancer National Cancer Center Hospital Gyeonggi-do Republic of Korea.
Source: MedComm [MedComm (2020)] 2025 Aug 19; Vol. 6 (9), pp. e70335. Date of Electronic Publication: 2025 Aug 19 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: China NLM ID: 101769925 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-2663 (Electronic) Linking ISSN: 26882663 NLM ISO Abbreviation: MedComm (2020) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40843133
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: VEGF Signal Complexity Confers Resistance to Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in EGFR-Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hong+S%22">Hong S</searchLink>; Research Institute National Cancer Center Gyeonggi Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Yu+N%22">Yu N</searchLink>; Research Institute National Cancer Center Gyeonggi Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Cho+JY%22">Cho JY</searchLink>; Research Institute National Cancer Center Gyeonggi Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+GK%22">Lee GK</searchLink>; Center for Lung Cancer National Cancer Center Hospital Gyeonggi-do Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Ahn+BC%22">Ahn BC</searchLink>; Research Institute National Cancer Center Gyeonggi Republic of Korea.; Center for Lung Cancer National Cancer Center Hospital Gyeonggi-do Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+Y%22">Lee Y</searchLink>; Research Institute National Cancer Center Gyeonggi Republic of Korea.; Center for Lung Cancer National Cancer Center Hospital Gyeonggi-do Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Sim+H%22">Sim H</searchLink>; National Cancer Center Graduate School of Cancer Science and Policy Gyeonggi Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Song+BR%22">Song BR</searchLink>; Research Institute National Cancer Center Gyeonggi Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Hwang+M%22">Hwang M</searchLink>; Research Institute National Cancer Center Gyeonggi Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+S%22">Kim S</searchLink>; Research Institute National Cancer Center Gyeonggi Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+JH%22">Kim JH</searchLink>; Research Institute National Cancer Center Gyeonggi Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Park+C%22">Park C</searchLink>; Research Institute National Cancer Center Gyeonggi Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Han+JY%22">Han JY</searchLink>; Research Institute National Cancer Center Gyeonggi Republic of Korea.; Center for Lung Cancer National Cancer Center Hospital Gyeonggi-do Republic of Korea.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101769925%22">MedComm</searchLink> [MedComm (2020)] 2025 Aug 19; Vol. 6 (9), pp. e70335. <i>Date of Electronic Publication: </i>2025 Aug 19 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons%2C+Inc%22">John Wiley & Sons, Inc </searchLink><i>Country of Publication: </i>China <i>NLM ID: </i>101769925 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2688-2663 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226882663%22">26882663 </searchLink><i>NLM ISO Abbreviation: </i>MedComm (2020) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40843133
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/mco2.70335
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e70335
    Titles:
      – TitleFull: VEGF Signal Complexity Confers Resistance to Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in EGFR-Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hong S
      – PersonEntity:
          Name:
            NameFull: Yu N
      – PersonEntity:
          Name:
            NameFull: Cho JY
      – PersonEntity:
          Name:
            NameFull: Lee GK
      – PersonEntity:
          Name:
            NameFull: Ahn BC
      – PersonEntity:
          Name:
            NameFull: Lee Y
      – PersonEntity:
          Name:
            NameFull: Sim H
      – PersonEntity:
          Name:
            NameFull: Song BR
      – PersonEntity:
          Name:
            NameFull: Hwang M
      – PersonEntity:
          Name:
            NameFull: Kim S
      – PersonEntity:
          Name:
            NameFull: Kim JH
      – PersonEntity:
          Name:
            NameFull: Park C
      – PersonEntity:
          Name:
            NameFull: Han JY
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 08
              Text: 2025 Aug 19
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2688-2663
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: MedComm
              Type: main
ResultId 1